Investing.com - Amgen (NASDAQ:AMGN) reported fourth quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $3.42 on revenue of $6.23B. Analysts polled by Investing.com forecast EPS of $3.28 on revenue of $5.86B. That compared to EPS of $2.89 on revenue of $5.80B in the same period a year earlier. The company had reported EPS of $3.69 on revenue of $5.9B in the previous quarter.
Amgen shares lost 2.92% to trade at $186.50 in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
On January 22, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar